31%OFF
Drug Compounding Pharmacies: Risks & Oversight Issues
Seth Sharpe
€ 199.92
€ 137.30
FREE Delivery in Ireland
Description for Drug Compounding Pharmacies: Risks & Oversight Issues
Hardback. Num Pages: 137 pages. BIC Classification: MMG. Category: (G) General (US: Trade). Dimension: 230 x 169 x 17. Weight in Grams: 382.
In light of the 2012 fungal meningitis outbreak, believed to have been caused by a contaminated compounded steroid injection, the regulation of human drug compounding has received significant attention. Drug compounding in its traditional form is the process of combining, mixing, or altering ingredients in order to create a medication for a particular patient. However, as illustrated by the entity that created the steroid medication linked with the meningitis outbreak, concerns have been raised about compounding pharmacies producing drugs on a larger scale. While drug compounding has historically been the focus of state governments through their regulation of pharmacies, questions ... Read more
In light of the 2012 fungal meningitis outbreak, believed to have been caused by a contaminated compounded steroid injection, the regulation of human drug compounding has received significant attention. Drug compounding in its traditional form is the process of combining, mixing, or altering ingredients in order to create a medication for a particular patient. However, as illustrated by the entity that created the steroid medication linked with the meningitis outbreak, concerns have been raised about compounding pharmacies producing drugs on a larger scale. While drug compounding has historically been the focus of state governments through their regulation of pharmacies, questions ... Read more
Product Details
Format
Hardback
Publication date
2013
Publisher
Nova Science Publishers Inc
Number of pages
137
Condition
New
Number of Pages
137
Place of Publication
New York, United States
ISBN
9781628081763
SKU
V9781628081763
Shipping Time
Usually ships in 5 to 9 working days
Ref
99-2
Reviews for Drug Compounding Pharmacies: Risks & Oversight Issues